Dimerix Limited Announces Appointment of Dr David Fuller as Chief Medical Officer
Position
Chief Medical Officer
Company
Dimerix Limited
MelbourneBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Dimerix Limited announced the appointment of Dr David Fuller as Chief Medical Officer. Dr Fuller is an internationally experienced pharmaceutical executive and physician with over 30 years' experience across pre-clinical and clinical development, as well as medical and regulatory affairs, and was the former CMO of Race Oncology. Dr Fuller, who has a strong fundamental background in the Dimerix technology having worked with Dimerix prior to public listing, will be responsible for the strategic delivery of the company's flagship ACTION3 Phase 3 clinical program for focal segmental glomerulosclerosis kidney disease currently recruiting globally.
Quick answer
Dimerix Limited Announces Appointment of Dr David Fuller as Chief Medical Officer (October 23, 2023). Dimerix Limited is based in Melbourne, Victoria, Australia.
- Who is the new Chief Medical Officer at Dimerix Limited?
- Dimerix Limited named David Fuller Chief Medical Officer, announced October 23, 2023.
- What did Dimerix Limited announce on October 23, 2023?
- Dimerix Limited announced the appointment of Dr David Fuller as Chief Medical Officer. Dr Fuller is an internationally experienced pharmaceutical executive and physician with over 30 years' experience across pre-clinical and clinical development, as well as medical and regulatory affairs, and was the former CMO of Race Oncology.
- What does Dimerix Limited do?
- Dimerix is a clinical-stage biopharmaceutical company, with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases.
- Where is Dimerix Limited based?
- Dimerix Limited is based in Melbourne, Victoria, Australia.
- Which similar companies made leadership changes around the same time?
- vTv Therapeutics Inc. (November 2, 2023), Arbutus (November 7, 2023), Madrigal Pharmaceuticals (November 10, 2023) and AnHeart Therapeutics (September 28, 2023) also announced leadership changes within 45 days of Dimerix Limited.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer (November 2, 2023)
- Arbutus Announces CEO, William Collier, to Retire December 31, 2023 (November 7, 2023)
- Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial Officer (November 10, 2023)
- AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer (September 28, 2023)
- Pfizer appoints new chief IR officer (September 28, 2023)
- Royalty Pharma Appoints Eric Schneider as Chief Technology (September 21, 2023)
Who to call at Dimerix Limited, and when
A new leader at Dimerix Limited brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Dimerix Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dimerix Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dimerix Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dimerix Limited changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dimerix Limited changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.